Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jones

Showing results (1321-1330 of 6,223) with videos related to

Pageof 623
Sort By:
Journal of Medical Virology|January 1, 1980
Non-A, non-B hepatitis in patients receiving blood productsS J Skidmore, T E Jones, E H Boxall
Blood|January 1, 1981
The chemotherapy of lymphoblastic lymphomaJ B Voakes, S E Jones, E M McKelvey
Critical Care Medicine|February 22, 2011
Cost-effectiveness of an emergency department-based early sepsis resuscitation protocolAlan E Jones, Jennifer L Troyer, Jeffrey A Kline
The American Journal of Pathology|October 8, 2009
Subcellular localization of the HER4 intracellular domain, 4ICD, identifies distinct prognostic outcomes for breast cancer patientsAnn D Thor, Susan M Edgerton, Frank E Jones
Journal of Visual Communication in Medicine|March 9, 2011
Development of an evidence-based patient information medium: empowering newly diagnosed patients with primary biliary cirrhosisRuth M Pearce, David E Jones, Julia L Newton
Nanotechnology|July 11, 2015
Single-electron and quantum confinement limits in length-scaled silicon nanowiresChen Wang, Mervyn E Jones, Zahid A K Durrani
Cancer Treatment Reports|November 1, 1984
Phase II trial of vinzolidine, an oral vinca alkaloid, in Hodgkin's disease and non-Hodgkin's lymphomaB J Takasugi, S E Jones, A B Robertone
Cancer Treatment Reports|April 1, 1982
Mistaken clinical and pathologic diagnoses of Hodgkin's disease: a Southwest oncology group studyT P Miller, G E Byrne, S E Jones
Progress in Clinical and Biological Research|January 1, 1980
Soft-agar cloning of cells from patients with lymphomaA W Hamburger, S E Jones, S E Salmon
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedureH E Jones, G E Bigelow, K L Preston
Pageof 623

Showing results (1321-1330 of 6,223) with videos related to

Sort By:
Pageof 623
Journal of Medical Virology|January 1, 1980
Non-A, non-B hepatitis in patients receiving blood productsS J Skidmore, T E Jones, E H Boxall
Blood|January 1, 1981
The chemotherapy of lymphoblastic lymphomaJ B Voakes, S E Jones, E M McKelvey
Critical Care Medicine|February 22, 2011
Cost-effectiveness of an emergency department-based early sepsis resuscitation protocolAlan E Jones, Jennifer L Troyer, Jeffrey A Kline
The American Journal of Pathology|October 8, 2009
Subcellular localization of the HER4 intracellular domain, 4ICD, identifies distinct prognostic outcomes for breast cancer patientsAnn D Thor, Susan M Edgerton, Frank E Jones
Journal of Visual Communication in Medicine|March 9, 2011
Development of an evidence-based patient information medium: empowering newly diagnosed patients with primary biliary cirrhosisRuth M Pearce, David E Jones, Julia L Newton
Nanotechnology|July 11, 2015
Single-electron and quantum confinement limits in length-scaled silicon nanowiresChen Wang, Mervyn E Jones, Zahid A K Durrani
Cancer Treatment Reports|November 1, 1984
Phase II trial of vinzolidine, an oral vinca alkaloid, in Hodgkin's disease and non-Hodgkin's lymphomaB J Takasugi, S E Jones, A B Robertone
Cancer Treatment Reports|April 1, 1982
Mistaken clinical and pathologic diagnoses of Hodgkin's disease: a Southwest oncology group studyT P Miller, G E Byrne, S E Jones
Progress in Clinical and Biological Research|January 1, 1980
Soft-agar cloning of cells from patients with lymphomaA W Hamburger, S E Jones, S E Salmon
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedureH E Jones, G E Bigelow, K L Preston
Pageof 623